
CAS 1361224-53-4
:Formel:C21H20F6N4O3S
InChl:InChI=1S/C21H20F6N4O3S/c1-2-3-16-13-30(35(33,34)17-8-9-18(28)29-12-17)10-11-31(16)15-6-4-14(5-7-15)19(32,20(22,23)24)21(25,26)27/h4-9,12,16,32H,10-11,13H2,1H3,(H2,28,29)/t16-/m0/s1
InChI Key:SIFKNECWLVONIH-INIZCTEOSA-N
SMILES:CC#C[C@H]1CN(CCN1C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O)S(=O)(=O)C3=CN=C(C=C3)N
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
5 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
AMG-3969
CAS:AMG-3969 is an effective glucokinase-glucokinase regulatory protein interaction (GK-GKRP) disruptor (IC50: 4 nM).Formel:C21H20F6N4O3SReinheit:99.65%Farbe und Form:SolidMolekulargewicht:522.464AMG3969
CAS:(S)-2-(4-(4-((6-Aminopyridin-3-yl)sulfonyl)-2-(prop-1-yn-1-yl)piperazin-1-yl)phenyl)-1,1,1,3,3,3-hexafluoropropan-2-olFormel:C21H20F6N4O3SReinheit:99%Molekulargewicht:522.46AMG-3969
CAS:AMG-3969 is a piperazine derivative with a potent profile that inhibits the gluconeogenic enzymes. It has been shown to have regulatory effects on pancreatic cells and animals in vitro and in vivo. AMG-3969 is also effective at inhibiting uptake of glucose from the blood by cells in vitro, which may lead to antidiabetic effects. It is also synthesized using an asymmetric synthesis, making it a unique molecule that has not been seen before. The safety profile of AMG-3969 has been demonstrated in preclinical studies.Formel:C21H20F6N4O3SReinheit:Min. 95%Molekulargewicht:522.46 g/mol




